ClinicalTrials.Veeva
Menu

Find clinical trials for Glioblastoma (GBM) in Tampa, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Glioblastoma
Recurrence
Brain Cancer
Glioma
Astrocytoma
Cancer
Gliosarcoma

Glioblastoma (GBM) trials near Tampa, FL, USA:

INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)

efficacy of INO-5401 and INO-9012 in combination with cemiplimab (REGN2810), with radiation and chemotherapy, in subjects with newly-diagnosed glioblastoma...

Active, not recruiting
Glioblastoma
Drug: Temozolomide
Biological: INO-5401

Phase 1, Phase 2

Inovio Pharmaceuticals
Inovio Pharmaceuticals

Tampa, Florida, United States and 20 other locations

The primary purpose of the study is to determine the efficacy of an investigational therapy called DCVax(R)-L in patients with newly diagnosed GBM...

Active, not recruiting
Glioblastoma
Glioblastoma Multiforme
Drug: Dendritic cell immunotherapy

Phase 3

Northwest Biotherapeutics
Northwest Biotherapeutics

Tampa, Florida, United States and 85 other locations

In summary, standard of care postoperative chemoradiation for patients with newly diagnosed GBM does not routinely provide durable local con...

Enrolling
Glioblastoma
Device: Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide)

Phase 4

GT Medical Technologies

Tampa, Florida, United States and 10 other locations

Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/II....

Enrolling
Glioblastoma
Drug: Temozolomide
Radiation: Radiation

Phase 2, Phase 3

Global Coalition for Adaptive Research

Tampa, Florida, United States and 61 other locations

This is an open-label, monotherapy study of pemigatinib in participants with recurrent glioblastoma (GBM) or other recurrent glioma...

Active, not recruiting
Glioblastoma
Adult-type Diffuse Gliomas
Drug: Pemigatinib

Phase 2

Incyte
Incyte

Tampa, Florida, United States and 80 other locations

This is a Phase 1 dose-escalation study of PRT3645, a Cyclin-dependent Kinase 4/6 (CDK4/6) inhibitor, in patients with advanced or metastatic solid t...

Active, not recruiting
Glioblastoma
Endometrial Cancer
Drug: PRT3645

Phase 1

Prelude Therapeutics

Sarasota, Florida, United States and 12 other locations

the return of cancer in patients with a newly diagnosed or recurrent glioblastoma multiforme (GBM) in combination with standard che...

Enrolling
Glioblastoma
Biological: Allogeneic genetically modified gamma-delta T cells
Biological: Autologous genetically modified gamma-delta T cells

Phase 1, Phase 2

In8bio

Tampa, Florida, United States and 6 other locations

To test the effectiveness and safety of Optune® given concomitantly with radiation therapy (RT) and temozolomide (TMZ) in newly diagnosed GBM...

Active, not recruiting
Glioblastoma Multiforme
Device: Optune®
NovoCure
NovoCure

Tampa, Florida, United States and 132 other locations

Researchers are looking for a better way to treat people with solid tumors. Before a treatment can be approved for people to take, researchers do cli...

Active, not recruiting
Solid Tumors
Drug: Regorafenib, (Stivarga, BAY73-4506)
Drug: Nivolumab (Opdivo)

Phase 2

Bayer
Bayer

Tampa, Florida, United States and 33 other locations

CC-90010-GBM-001 is a multi-center, open-label study to assess the pharmacokinetics (PK), pharmacodynamics (PD) and CNS penetration of CC-90...

Active, not recruiting
Glioblastoma
Astrocytoma
Drug: CC-90010

Phase 1

Celgene
Celgene

Tampa, Florida, United States and 3 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems